Angiotech Pharmaceuticals to Participate in Lehman Brothers Global Healthcare Conference
25 Februar 2004 - 10:05PM
PR Newswire (US)
Angiotech Pharmaceuticals to Participate in Lehman Brothers Global
Healthcare Conference VANCOUVER, Feb. 25 /PRNewswire-FirstCall/ --
Angiotech Pharmaceuticals, Inc. , is scheduled to participate in
the Lehman Brothers 7th Annual Global Healthcare Conference.
William Hunter, President and CEO of Angiotech, will be making a
25- minute presentation at the conference on Wednesday, March 3rd,
beginning at 5:15 pm EST (2:15 pm PST). A live audio only webcast
of Dr. Hunter's remarks will be available to all interested parties
at Angiotech's website at http://www.angiotech.com/ in the Investor
Relations section. To ensure a timely connection to the webcast, it
is recommended that users register at least 15 minutes before the
webcast begins. This webcast is being hosted by Lehman Brothers.
The replay will be archived and available until Wednesday, March
10th in the Investor Relations section of Angiotech's website at
http://www.angiotech.com/. Angiotech Pharmaceuticals, Inc. is
dedicated to enhancing the performance of medical devices and
biomaterials through the innovative use of pharmacotherapeutics. To
find out more about Angiotech Pharmaceuticals, Inc
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), visit our website at
http://www.angiotech.com/. Company Contacts: Rui Avelar (analysts),
ext 6996 Ian Harper (investors and media), ext 6933 Phone: (604)
221-7676 Web: http://www.angiotech.com/ Email: DATASOURCE:
Angiotech Pharmaceuticals, Inc. CONTACT: Rui Avelar (analysts), ext
6996; Ian Harper (investors and media), ext 6933, Phone:
604-221-7676, Web: http://www.angiotech.com/, Email:
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals (MM) News-Artikel